Sodium–glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure

BackgroundAcute coronary syndrome (ACS) remains a risk factor for heart failure (HF). Therefore, we aimed to assess the cardioprotective role of sodium–glucose cotransporter-2 (SGLT2) inhibitors post-ACS in patients with acute HF (AHF) and diabetes.MethodsWe conducted a retrospective observational c...

詳細記述

書誌詳細

主要な著者:	Alaa Rahhal, Tahseen Hamamyh, Ammar Chapra, Khaled J. Zaza, Mostafa Najim, Mohammad Hemadneh, Hazem Faraj, Wael Kanjo, Ahmed Yasin, Haneen Toba, Wafa Mohammed, Mohammad Khair Hamad, Nawras Al-Tikrety, Mhd Baraa Habib, Ahmed Awaisu, Ahmed Mahfouz, Sumaya Alyafei, Abdul Rahman Arabi, Ashfaq Patel, Mohammed Al-Hijji
フォーマット:	Artigo
言語:	Inglês
出版事項:	Frontiers Media S.A. 2024-05-01
シリーズ:	Frontiers in Cardiovascular Medicine
主題:	acute coronary syndrome heart failure sodium–glucose cotransporter-2 (SGLT-2) inhibitors HF hospitalization cardioprotection
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fcvm.2024.1383669/full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!